Tag: Earnings
Cerebras Stock Sold Off After Earnings. Investors Who Panic Sell Are Ignoring the Smart Money.
Cerebras Systems (CBRS), a company known for designing AI chips and developing AI infrastructure, recently faced a significant…
PayPal Trades at Less Than 8X Earnings. Is This a Bargain or a Value Trap?
PayPal (NASDAQ: PYPL) is currently trading at just 7.6 times earnings, which is quite low for a company…
J.Jill Q1 Earnings Call Highlights
J.Jill (NYSE:JILL) recently reported its first-quarter results, which were in line with expectations but still showed declines in…
Quanex Building Products Q2 Earnings Call Highlights
Quanex Building Products (NYSE:NX) recently released its fiscal second-quarter earnings report, showing a moderate increase in revenue but…
Sprinklr (CXM) Q1 2027 Earnings Transcript
The transformation journey of Sprinklr, a leading customer experience management platform, is well underway. As they continue to…
Snowflake (SNOW) Soars 36% as AI Propels Q1 Earnings
Snowflake Inc. (NYSE:SNOW) is making waves in the stock market, with its share prices soaring by 36.48 percent…
Dycom (DY) Q1 2027 Earnings Call Transcript
Dycom Industries, a leading provider of specialty contracting services, has reported strong financial results for the first quarter…
Digital Turbine, Inc. Q4 2026 Earnings Call Summary
Digital Turbine, Inc. recently held its Q4 2026 earnings call, revealing impressive strategic performance drivers that have propelled…
Intuit earnings put Morgan Stanley stock forecast to the test
Intuit's latest earnings report showcased solid growth in the company's fiscal third quarter, affirming the bullish outlook presented…
Lionsgate Quarterly Earnings Improve Thanks to ‘The Housemaid’
Revenue surged, and profits were revitalized in Lionsgate's latest quarter, attributed to the box office success of “The…
Planet Fitness Stock Plunged Following Earnings. Should You Buy?
The current earnings season is not over yet, but Planet Fitness (NYSE: PLNT) is on track to become…
Zevra Therapeutics Q1 Earnings Call Highlights
Zevra Therapeutics, a leading biopharmaceutical company, recently released its first-quarter 2026 financial results, showcasing impressive growth and progress…